CME Online Activities

Appraisal of Recent Progress in Metastatic Castration-Resistant Prostate Cancer: Current Trends and Future Directions

Appraisal of Recent Progress in Metastatic Castration-Resistant Prostate Cancer: Current Trends and Future Directions

This case-based online activity features Oliver Sartor, MD from Tulane Cancer Center as he examines recent developments and best practices in treatment selection and supportive care planning for patients with metastatic CRPC.

CME-certified online activity

Selecting Optimal Antiangiogenic Strategies for Patients With Hepatocellular Carcinoma

Selecting Optimal Antiangiogenic Strategies for Patients With Hepatocellular Carcinoma

This activity features an expert-led, case-based discussion with Thomas A. Abrams, MD from Dana-Farber Cancer Institute and Harvard Medical School on evolving antiangiogenic strategies with multikinase inhibitors in first- and second-line treatment of advanced HCC. Participate from the comfort of your home or office.

CME or CE credit available

Selecting Optimal Therapeutic Strategies for Patients With Differentiated and Medullary Thyroid Cancer

Selecting Optimal Therapeutic Strategies for Patients With Differentiated and Medullary Thyroid Cancer

In this case-based activity, leading clinical investigator Jochen Lorch, MD, MS from Dana-Farber Cancer Institute will share insights into evidence-based personalized care planning for patients with differentiated and medullary thyroid cancer. Enroll now!

CME-certified online activity

Defining Personalized Care Plans in Metastatic Castration-Resistant Prostate Cancer

Defining Personalized Care Plans in Metastatic Castration-Resistant Prostate Cancer

Watch this CME/CE certified discussion with Tanya Dorff, MD from the Keck School of Medicine as she discusses progress in our understanding of predictive/prognostic markers in advanced prostate cancer as well as optimizing treatment sequencing and response assessment.

CME or CE credit available

CME Local Meetings

New Directions in the Management of Recurrent Ovarian Cancer: Focus on PARP Inhibitors

New Directions in the Management of Recurrent Ovarian Cancer: Focus on PARP Inhibitors

This activity will bring a leading clinical investigator to your cancer center to discuss emerging data on PARP inhibitors that can rationally inform the management of ovarian cancer. Enroll your institution today!

Format: CME-certified visiting faculty lecture series

Challenges and Opportunities in Metastatic Castration-Resistant Prostate Cancer: A CME/CE/CPE-Certified VA/DoD Meeting Series

Challenges and Opportunities in Metastatic Castration-Resistant Prostate Cancer: A CME/CE/CPE-Certified VA/DoD Meeting Series

This live activity will bring a leading clinical investigator to your VA/DoD medical center to discuss emerging data on treatment selection, resistance, and response in CRPC. Book a meeting today!

Format: CME/CE/CPE-certified visiting faculty meeting series

New Directions in the Management of Graft-Versus-Host Disease

New Directions in the Management of Graft-Versus-Host Disease

Graft-versus-host disease is a major complication of hematopoietic stem cell transplant, occurring in 40% to 60% of patients. Book this live meeting at your institution to learn more about risk assessment, prophylaxis, and emerging data on therapeutic selection.

Format: CME-certified hem/onc fellows lecture series

Current Trends and Future Directions in Targeted Therapies for Advanced Renal Cell Carcinoma

Current Trends and Future Directions in Targeted Therapies for Advanced Renal Cell Carcinoma

This activity will bring a leading clinical investigator to your cancer center to discuss emerging data on targeted therapies in the treatment of patients with advanced renal cell carcinoma. Enroll your institution today.

Format: CME-certified visiting faculty meeting series

Optimizing the Treatment of Hematologic Malignancies With Hematopoietic Stem Cell Transplant

Optimizing the Treatment of Hematologic Malignancies With Hematopoietic Stem Cell Transplant

This activity will bring a leading clinical investigator to your hematology/oncology fellowship program to discuss emerging data that can rationally inform the management of hematologic malignancies with stem cell transplant. Enroll your institution today!

Format: CME-certified hem/onc fellows lecture series

Optimizing the Treatment of Metastatic Merkel Cell Carcinoma With Immune Checkpoint Inhibitors

Optimizing the Treatment of Metastatic Merkel Cell Carcinoma With Immune Checkpoint Inhibitors

Immunotherapy is disrupting cancer care! This activity will bring a clinical expert to your cancer center to share insights into how immune checkpoint inhibitors can enhance the survival outcomes of patients with metastatic MCC. Enroll your institution now.

Format: CME/CE-certified visiting faculty meeting series